Tafamidis Meglumine 11014-0207-04
- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- Capsule
- Product Type
- Drug For Further Processing
- Marketing Start
- May 5, 2016
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tafamidis Meglumine | 20 mg/1 |
Selected Package
11014-0207-04Selected2 BAG in 1 CARTON (11014-0207-4) / 1500 CAPSULE in 1 BAG